Profile of temsirolimus in the treatment of advanced renal cell carcinoma

被引：8
|
作者：
Staehler, Michael [1 ]
Haseke, Nicolas [1 ]
Khoder, Wael [1 ]
Stief, Christian G. [1 ]
机构：
[1] Univ Munich, Dept Urol, Klinikum Grosshadern, D-81377 Munich, Germany
来源：
ONCOTARGETS AND THERAPY | 2010年 / 3卷
关键词：
renal cell cancer; nonclear cell renal cancer; temsirolimus; first-line therapy; overall survival; nephrectomy; INTERFERON-ALPHA; PROGNOSTIC-FACTORS; SURVIVAL; NEPHRECTOMY; CANCER;
D O I：
10.2147/OTT.S7657
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Temsirolimus is a potent inhibtor of the mammalian target of rapamycin (mTOR). In various clinical trials temsirolimus has shown an overall survival benefit for patients with metastatic renal cell carcinoma (mRCC). Thus it is approved for first-line therapy in high-risk mRCC patients. We discuss the indication, side effects and clinical implications of temsirolimus treatment.
引用
收藏
页码：191 / 196
页数：6
相关论文
共 50 条
  • [1] Temsirolimus in the treatment of advanced renal cell carcinoma
    Gore, M. E.
    ANNALS OF ONCOLOGY, 2007, 18 : 87 - 88
  • [2] Temsirolimus in the treatment of advanced renal cell carcinoma
    Escudier, Bernard J.
    ONCOLOGY REVIEWS, 2007, 1 (02) : 73 - 80
  • [3] Temsirolimus in the treatment of advanced renal-cell carcinoma
    Zolnierek, Jakub
    ONCOLOGY IN CLINICAL PRACTICE, 2009, 5 : C12 - C20
  • [4] Temsirolimus for advanced renal cell carcinoma
    Bergmann, Lothar
    Maute, Luise
    Guschmann, Michael
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (01) : 9 - 21
  • [5] Temsirolimus - In advanced renal cell carcinoma
    Simpson, Dene
    Curran, Monique P.
    DRUGS, 2008, 68 (05) : 631 - 638
  • [6] Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma
    Zanardi, Elisa
    Verzoni, Elena
    Grassi, Paolo
    Necchi, Andrea
    Giannatempo, Patrizia
    Raggi, Daniele
    De Braud, Filippo
    Procopio, Giuseppe
    THERAPEUTIC ADVANCES IN UROLOGY, 2015, 7 (03) : 152 - 161
  • [7] Temsirolimus: a review of its use in the treatment of advanced renal cell carcinoma
    Chan, Fanny
    Samlowski, Erika E.
    Samlowski, Wolfram E.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 167 - 174
  • [8] Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma
    Malizzia, Lois J.
    Hsu, Arlene
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (04) : 639 - 646
  • [9] FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma
    Kwitkowski, Virginia E.
    Prowell, Tatiana M.
    Ibrahim, Amna
    Farrell, Ann T.
    Justice, Robert
    Mitchell, Shan Sun
    Sridhara, Rajeshwari
    Pazdur, Richard
    ONCOLOGIST, 2010, 15 (04): : 428 - 435
  • [10] Temsirolimus in patients with advanced renal cell carcinoma: an overview
    Shailender Bhatia
    John A. Thompson
    Advances in Therapy, 2009, 26
12345